IndiaOne Finance - Company Dashboard

Governance Classic Home

Everest Organics LtdPharmaceuticalsINE334C01029Standalone₹251.05+0.55 (+0.22%)Jun-26

Valuation

Market Cap₹243.78 Cr

TTM PE41.70x

Forward PE38.98x

PEG1.77

Book Value₹72.04

P/B3.49x

TTM EPS₹6.02

Fwd EPS₹6.44

TTM Revenue₹190.77 Cr

TTM PAT₹4.80 Cr

TTM EBITDA₹19.69 Cr

TTM EBIT₹13.13 Cr

Last Qtr PAT₹1.11 Cr

Last Qtr EBITDA₹4.33 Cr

Last Qtr EBIT₹2.74 Cr

Profitability

ROE6.86%

ROCE12.00%

TTM NPM2.52%

TTM EBITDA %10.32%

Curr OPM2.30%

Last OPM4.46%

Curr NPM—

Last NPM—

Curr EPS₹1.15

Last EPS₹2.69

Balance sheet

Equity₹9.71 Cr

Reserve₹60.24 Cr

Total Debt₹47.88 Cr

D/E0.68x

Interest %146.85%

Curr Interest₹1.63 Cr

Price / range

Close₹251.05

vs 52W High-53.20%

vs 52W Low+27.44%

MA50—

MA200—

Returns

1D+0.22%

1W-5.30%

1M-20.90%

3M-7.52%

6M-12.57%

1Y-39.07%

2Y+84.32%

3Y+114.85%

5Y-18.33%

Diwali-49.79%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	48.43-10.0%	48.75	42.59	51	53.81	196.16
Other Income	0.42	0.16	0.25	0.29	0.55	1.25
Total Income	48.85-10.1%	48.91	42.84	51.29	54.36	197.40
Interest	1.63	2.76	1.23	1.23	1.31	6.53
Expenditure	-47.32+9.2%	-46.74	-41.81	-48.62	-52.10	-189.36
PBDT	0	0	0	0	0	0
EBITDA	4.33-4.6%	6.70	3.53	5.13	4.54	19.81
Depreciation	-1.59	-1.93	-1.52	-1.52	-1.52	-6.48
EBIT	2.74-9.3%	4.77	2.01	3.61	3.02	13.33
PBT	1.53-29.2%	2.17	1.04	2.67	2.16	8.05
Tax	-0.42	0.46	-0.68	-1.52	-0.70	-2.50
Equity	0	0	0	0	0	0
OPM	3.16	4.46	2.43	5.24	4.02	4.00
Net Profit	1.11-21.3%	2.17	0.36	1.16	1.41	5.55
NPM	2.30	4.46	0.84	2.27	2.61	3.00
EPS	1.15	2.69	0.99	1.19	0	5.70

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	196.16+23.0%	159.48-19.1%	197.24+7.8%	183.05-8.5%	200.05+10.2%	181.57
Other Income	1.25	0.69	0.89	6.94	2.21	1.06
Total Income	197.40+23.2%	160.17-19.2%	198.13+4.3%	189.99-6.1%	202.26+10.7%	182.63
Expenditure	-189.36-15.9%	-163.41+17.3%	-197.52-4.0%	-189.90+5.3%	-200.52-21.3%	-165.36
Interest	-6.53	-5.19	-5.47	-3.31	-3.10	-3.26
PBDT	0	0	0	0	0	0
EBITDA	19.81+174.4%	7.22-34.3%	10.99+1081.7%	0.93-85.5%	6.43-71.8%	22.84
Depreciation	-6.48	-5.96	-5.80	-4.47	-3.80	-3.37
EBIT	13.33+957.9%	1.26-75.7%	5.19+246.6%	-3.54-234.6%	2.63-86.5%	19.47
PBT	8.05+348.5%	-3.24-631.1%	0.61+577.8%	0.09-94.8%	1.74-89.9%	17.27
Tax	-2.50	1.95	-0.47	-0.27	-0.60	-3.56
Equity	0	9.71	0	0	0	0
OPM (%)	4.00	-2.02	0.00	0.00	1.00	9.00
Net Profit	5.55+530.2%	-1.29-1021.4%	0.14+177.8%	-0.18-115.8%	1.14-91.7%	13.72
NPM (%)	3.00	-0.81	0.00	0.00	1.00	8.00
EPS (Rs)	5.70	0-100.0%	0.17+173.9%	-0.23-116.1%	1.43-91.7%	17.14
CEPS	5.70	0	0.17	-0.23	1.43	17.14

Metric	FY24-25
Revenue	159.48
Other Income	0.69
Total Income	160.17
Interest	5.19
Expenditure	-163.41
PBDT	0
EBITDA	7.22
Depreciation	-5.96
EBIT	1.26
PBT	-3.24
Tax	1.95
Equity	9.71
OPM	-2.02
Net Profit	-1.29
NPM	-0.81
EPS	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25
Revenue	159.48
Other Income	0.69
Total Income	160.17
Expenditure	-163.41
Interest	-5.19
PBDT	0
EBITDA	7.22
Depreciation	-5.96
EBIT	1.26
PBT	-3.24
Tax	1.95
Equity	9.71
OPM (%)	-2.02
Net Profit	-1.29
NPM (%)	-0.81
EPS (Rs)	0
CEPS	0

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2022	Final Dividend	0.5	15 Sep 2022
2021	Final Dividend	1	08 Sep 2021
2021	Interim Dividend	0.5	17 Feb 2021
2020	Final Dividend	1	01 Sep 2020
2019	Final Dividend	1	03 Sep 2019

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split